Paper39091016
Gilteritinib Reduces FLT3 Expression in Acute Myeloid Leukemia Cells.
Thái TL and 1 other. Biomol Ther (Seoul), 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Gilteritinib Reduces FLT3 Expression in Acute Myeloid Leukemia Cells. Papers, record 39091016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39091016
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31528345 | Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia. | Biomark Res | 2019 | https://conductscience.org/library/papers/31528345 | PubMed |
| 2 | 31309543 | Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies. | Br J Haematol | 2019 | https://conductscience.org/library/papers/31309543 | PubMed |
| 3 | 31493406 | Hematological malignancies and molecular targeting therapy. | Eur J Pharmacol | 2019 | https://conductscience.org/library/papers/31493406 | PubMed |
| 4 | 37433680 | Evaluation of hypereosinophilia in a case of FLT3-mutant acute myeloid leukemia treated with gilteritinib. | Cold Spring Harb Mol Case Stud | 2023 | https://conductscience.org/library/papers/37433680 | PubMed |
| 5 | 36518702 | Development of Gilteritinib-Based Chimeric Small Molecules that Potently Induce Degradation of FLT3-ITD Protein. | ACS Med Chem Lett | 2022 | https://conductscience.org/library/papers/36518702 | PubMed |
| 6 | 35923716 | FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms. | RSC Med Chem | 2022 | https://conductscience.org/library/papers/35923716 | PubMed |
| 7 | 19549778 | Structural and functional alterations of FLT3 in acute myeloid leukemia. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19549778 | PubMed |
| 8 | 28516360 | Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia. | Invest New Drugs | 2017 | https://conductscience.org/library/papers/28516360 | PubMed |
| 9 | 30651634 | Targeting FLT3 mutations in AML: review of current knowledge and evidence. | Leukemia | 2019 | https://conductscience.org/library/papers/30651634 | PubMed |
| 10 | 28276286 | Arsenic trioxide and all-trans-retinoic acid selectively exert synergistic cytotoxicity against FLT3-ITD AML cells via co-inhibition of FLT3 signaling pathways. | Leuk Lymphoma | 2017 | https://conductscience.org/library/papers/28276286 | PubMed |
| 11 | 30344940 | Heat shock protein 90 inhibitors overcome the resistance to Fms-like tyrosine kinase 3 inhibitors in acute myeloid leukemia. | Oncotarget | 2018 | https://conductscience.org/library/papers/30344940 | PubMed |
| 12 | 34959180 | Degrading FLT3-ITD protein by proteolysis targeting chimera (PROTAC). | Bioorg Chem | 2022 | https://conductscience.org/library/papers/34959180 | PubMed |
| 13 | 30651561 | Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms. | Nat Commun | 2019 | https://conductscience.org/library/papers/30651561 | PubMed |
| 14 | 30737839 | FLT3, a prognostic biomarker for acute myeloid leukemia (AML): Quantitative monitoring with a simple anti-FLT3 interaction and flow cytometric method. | J Clin Lab Anal | 2019 | https://conductscience.org/library/papers/30737839 | PubMed |
| 15 | 12529668 | FLT3 mutations in acute myeloid leukemia cell lines. | Leukemia | 2003 | https://conductscience.org/library/papers/12529668 | PubMed |
| 16 | 34694800 | Proteolysis-Targeting Chimera (PROTAC) Modification of Dovitinib Enhances the Antiproliferative Effect against FLT3-ITD-Positive Acute Myeloid Leukemia Cells. | J Med Chem | 2021 | https://conductscience.org/library/papers/34694800 | PubMed |
| 17 | 23840454 | Inhibition of FLT3 expression by green tea catechins in FLT3 mutated-AML cells. | PLoS One | 2013 | https://conductscience.org/library/papers/23840454 | PubMed |
| 18 | 24227820 | Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants. | Blood | 2014 | https://conductscience.org/library/papers/24227820 | PubMed |
| 19 | 27913501 | Mutations in AML: prognostic and therapeutic implications. | Hematology Am Soc Hematol Educ Program | 2016 | https://conductscience.org/library/papers/27913501 | PubMed |
| 20 | 24319184 | FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013? | Hematology Am Soc Hematol Educ Program | 2013 | https://conductscience.org/library/papers/24319184 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40790935 | Small-Molecule-Induced Protein Polymerization: Mechanisms and Therapeutic Implications. | Biomol Ther (Seoul) | 2025 | https://conductscience.org/library/papers/40790935 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FLT3 | 2322 | PubTator's text mining | https://conductscience.org/library/genes/2322 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39091016
GET https://conductscience.org/api/papers/v1/39091016/references?page=2